• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估食管胃结合部腺癌中阳性淋巴结比率的预后价值和分期迁移效应。

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.

机构信息

Division of Digestive Surgery (Gastric Surgery Division), Department of Surgery, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachihirokoji, Kamigyo-ku, 602- 8566, Kyoto, Japan.

出版信息

BMC Cancer. 2023 Mar 8;23(1):218. doi: 10.1186/s12885-023-10689-6.

DOI:10.1186/s12885-023-10689-6
PMID:36890486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9996992/
Abstract

BACKGROUND

Adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is an important clinical issue in AEG patients. This study investigated the usefulness of a positive lymph node ratio (PLNR) to stratify prognosis and evaluate stage migration.

METHODS

We retrospectively analysed 117 consecutive AEG patients (Siewert type I or II) who received a lymphadenectomy between 2000 and 2016.

RESULTS

A PLNR cut-off value of 0.1 most effectively stratified patient prognosis into two groups (P < 0.001). Also, prognosis could be clearly stratified into four groups: PLNR = 0, 0 < PLNR < 0.1, 0.1 ≤ PLNR < 0.2, and 0.2 ≤ PLNR (P < 0.001, 5-year survival rates (88.6%, 61.1%, 34.3%, 10.7%)). A PLNR ≥ 0.1 significantly correlated with tumour diameter ≥ 4 cm (P < 0.001), tumour depth (P < 0.001), greater pathological N-status (P < 0.001), greater pathological Stage (P < 0.001), and oesophageal invasion length ≥ 2 cm (P = 0.002). A PLNR ≥ 0.1 was a poor independent prognostic factor (hazard ratio 6.47, P < 0.001). The PLNR could stratify prognosis if at least 11 lymph nodes were retrieved. A 0.2 PLNR cut-off value discriminated a stage migration effect in pN3 and pStage IV (P = 0.041, P = 0.015) patients; PLNR ≥ 0.2 might potentially diagnose a worse prognosis and need meticulous follow-up post-surgery.

CONCLUSION

Using PLNR, we can evaluate the prognosis and detect higher malignant cases who need meticulous treatments and follow-up in the same pStage.

摘要

背景

食管胃结合部腺癌(AEG)在全球范围内呈上升趋势。淋巴结转移是 AEG 患者的一个重要临床问题。本研究旨在探讨阳性淋巴结比率(PLNR)在分层预后和评估分期迁移方面的作用。

方法

我们回顾性分析了 2000 年至 2016 年间接受淋巴结清扫术的 117 例 AEG 患者(Siewert Ⅰ型或Ⅱ型)。

结果

PLNR 截断值为 0.1 时,能最有效地将患者的预后分为两组(P<0.001)。此外,预后也可以分为四组:PLNR=0、0<PLNR<0.1、0.1≤PLNR<0.2 和 0.2≤PLNR(P<0.001,5 年生存率分别为 88.6%、61.1%、34.3%和 10.7%)。PLNR≥0.1 与肿瘤直径≥4cm(P<0.001)、肿瘤深度(P<0.001)、较大的病理 N 分期(P<0.001)、较大的病理分期(P<0.001)和食管侵犯长度≥2cm(P=0.002)显著相关。PLNR≥0.1 是一个不良的独立预后因素(危险比 6.47,P<0.001)。如果至少检出 11 个淋巴结,PLNR 可用于分层预后。0.2 的 PLNR 截断值可以区分 pN3 和 pStage IV 患者的分期迁移效应(P=0.041,P=0.015);PLNR≥0.2 可能提示预后更差,术后需要进行细致的随访。

结论

使用 PLNR,我们可以评估预后,并发现需要更细致治疗和随访的高恶性病例,即使在相同的 pStage 中也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/f89fb6f1e9b3/12885_2023_10689_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/d7539e8721a7/12885_2023_10689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/04bf57b1117a/12885_2023_10689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/f89fb6f1e9b3/12885_2023_10689_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/d7539e8721a7/12885_2023_10689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/04bf57b1117a/12885_2023_10689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b7/9996992/f89fb6f1e9b3/12885_2023_10689_Fig3_HTML.jpg

相似文献

1
Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.评估食管胃结合部腺癌中阳性淋巴结比率的预后价值和分期迁移效应。
BMC Cancer. 2023 Mar 8;23(1):218. doi: 10.1186/s12885-023-10689-6.
2
Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer.利用阳性淋巴结比率评估胃癌的预后价值及分期迁移效应
Eur J Surg Oncol. 2017 Jan;43(1):203-209. doi: 10.1016/j.ejso.2016.08.002. Epub 2016 Aug 21.
3
Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.胃食管结合部 Siewert Ⅱ/Ⅲ型腺癌胃周淋巴结清扫的临床意义:一项回顾性倾向评分匹配研究。
Langenbecks Arch Surg. 2022 May;407(3):985-998. doi: 10.1007/s00423-021-02380-w. Epub 2021 Nov 18.
4
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].[经胸与经腹入路治疗食管胃交界部Siewert II型腺癌的生存比较:胸外科与胃肠外科联合数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142.
5
The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.胃食管交界部Siewert II/III型腺癌中幽门旁淋巴结转移的预后相关性
Eur J Surg Oncol. 2017 Dec;43(12):2333-2340. doi: 10.1016/j.ejso.2017.08.017. Epub 2017 Sep 8.
6
[Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].[不同TNM分期系统在食管胃交界部Siewert III型腺癌中的优势比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):143-148.
7
Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.阳性淋巴结比率作为N3期胃癌预后和局部肿瘤清除的指标
J Gastrointest Surg. 2016 Sep;20(9):1565-71. doi: 10.1007/s11605-016-3197-9. Epub 2016 Jun 28.
8
Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.淋巴结比率是食管胃结合部 Siewert II 型腺癌患者的独立预后因素:一项 10 年随访研究的结果。
J Gastrointest Cancer. 2021 Sep;52(3):983-992. doi: 10.1007/s12029-020-00468-y.
9
Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.食管胃结合部 Siewert II/III 型腺癌的淋巴结转移风险因素评估和预后:一项回顾性研究。
Medicine (Baltimore). 2024 Mar 1;103(9):e37289. doi: 10.1097/MD.0000000000037289.
10
[Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].[机器人手术与腹腔镜辅助手术对食管胃交界部Siewert II型腺癌患者淋巴结清扫及短期预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):156-163.

引用本文的文献

1
Positive lymph node ratio as a nodal staging system to avoid stage migration between remnant and primary proximal gastric cancers.阳性淋巴结比率作为一种淋巴结分期系统,以避免残余近端胃癌和原发性近端胃癌之间的分期迁移。
Sci Rep. 2025 Aug 5;15(1):28623. doi: 10.1038/s41598-025-13766-x.
2
Evaluating the predictive value of log odds of positive lymph nodes on postoperative survival in patients with laryngeal cancer: a SEER population-based study.评估阳性淋巴结对数优势比对喉癌患者术后生存的预测价值:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Discov Oncol. 2025 Apr 2;16(1):452. doi: 10.1007/s12672-025-02193-z.
3
Prognostic significance of an innovative staging system based on the logarithmic odds of positive lymph nodes for resectable gastroesophageal cancer after neoadjuvant chemoradiation: a population-based study with external validation of data.

本文引用的文献

1
Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes.针对≤15枚检出淋巴结的食管胃交界腺癌预后预测的4种淋巴结分期系统比较
Eur J Surg Oncol. 2022 May;48(5):1017-1024. doi: 10.1016/j.ejso.2021.11.133. Epub 2021 Dec 1.
2
Cancer statistics for the year 2020: An overview.2020年癌症统计数据概述。
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
3
Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
基于对数阳性淋巴结比值的创新分期系统对新辅助放化疗后可切除胃食管交界癌预后意义的研究:基于人群的研究及数据外部验证
J Transl Med. 2024 Aug 29;22(1):801. doi: 10.1186/s12967-024-05448-5.
淋巴结比率是食管胃结合部 Siewert II 型腺癌患者的独立预后因素:一项 10 年随访研究的结果。
J Gastrointest Cancer. 2021 Sep;52(3):983-992. doi: 10.1007/s12029-020-00468-y.
4
Japanese gastric cancer treatment guidelines 2018 (5th edition).《日本胃癌治疗指南2018(第5版)》
Gastric Cancer. 2021 Jan;24(1):1-21. doi: 10.1007/s10120-020-01042-y. Epub 2020 Feb 14.
5
Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan.2017/2018年度重要更新:日本胃癌治疗与研究的最新课题
Ann Gastroenterol Surg. 2019 Aug 27;3(6):581-591. doi: 10.1002/ags3.12284. eCollection 2019 Nov.
6
Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.胃食管结合部肿瘤淋巴结转移的定位:一项全国前瞻性多中心研究。
Ann Surg. 2021 Jul 1;274(1):120-127. doi: 10.1097/SLA.0000000000003499.
7
Role of lymph node yield and lymph node ratio in predicting outcomes in non-metastatic colorectal cancer.淋巴结检出数和淋巴结比值在预测非转移性结直肠癌结局中的作用。
BJS Open. 2018 Aug 8;3(1):95-105. doi: 10.1002/bjs5.96. eCollection 2019 Feb.
8
The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.内脏脂肪组织量对结直肠癌手术中淋巴结清扫充分性的影响。
J Surg Oncol. 2018 Mar;117(3):523-528. doi: 10.1002/jso.24876. Epub 2017 Nov 9.
9
Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction.三种用于食管胃结合部 Siewert Ⅱ型腺癌患者淋巴结分期方案的预后性能。
Sci Rep. 2017 Aug 31;7(1):10123. doi: 10.1038/s41598-017-09625-z.
10
Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.一项关于食管胃交界癌淋巴结清扫术的全国性回顾性研究结果。
Gastric Cancer. 2017 Mar;20(Suppl 1):69-83. doi: 10.1007/s10120-016-0663-8. Epub 2016 Oct 28.